McDermott + Bull Partner Ken Dropiewski talks with H.I.G. Capital Managing Director Gwen Watanabe about what her team looks for in prospective partners for new venture opportunities.
Tag: InvestorInsights
Investor Insights: Gwen Watanabe – How Do You See Venture in MedTech Looking in 2023?
McDermott + Bull Partner Ken Dropiewski talks with H.I.G. Capital Managing Director Gwen Watanabe about what she’s expecting to see in the venture capital space in 2023.
Investor Insights: Gwen Watanabe – At What Stage Does H.I.G. Capital Typically Invest?
McDermott + Bull Partner Ken Dropiewski talks with H.I.G. Capital Managing Director Gwen Watanabe about when they typically invest.
Investor Insights: Geoff Pardo – What is Your Typical Investment Size? (Part 3)
McDermott + Bull Partner Ken Dropiewski interviews Gilde Healthcare General Partner Geoff Pardo in his series, Investor Insights in Life Sciences + MedTech. In the conversations below, Ken and Geoff discuss what venture in MedTech will look like in 2023, what Gilde Healthcare looks for in new investment opportunities, and more.
Investor Insights: Geoff Pardo – How Do You See Venture in MedTech Looking In 2023? (Part 2)
McDermott + Bull Partner Ken Dropiewski talks with Gilde Healthcare General Partner Geoff Pardo about what his team looks for in prospective partners in new venture opportunities.
Investor Insights: Geoff Pardo – How Do You See Venture in MedTech Looking In 2023? (Part 1)
McDermott + Bull Partner Ken Dropiewski talks with Gilde Healthcare General Partner Geoff Pardo about what he’s expecting to see in the venture capital space in 2023.
Investor Insights: Rob Barmann – Non-Traditional MedTech Services (Part 5)
McDermott + Bull Partner Ken Dropiewski interviews Endeavour Venture Partner Rob Barmann in his series, Investor Insights in Life Sciences + MedTech. In the conversations below, Ken and Rob discuss a range of topics from typical investment sizes to non-traditional MedTech services.
Investor Insights: Rob Barmann – What is Your Typical Investment Size? (Part 4)
McDermott + Bull Partner Ken Dropiewski talks with Endeavour Vision Partner Rob Barmann about typical investment sizes in their portfolio companies.
Investor Insights: Rob Barmann – How Do You See Venture in MedTech Looking In 2023? (Part 3)
McDermott + Bull Partner Ken Dropiewski talks with Endeavour Vision Partner Rob Barmann about what he’s expecting to see in the venture capital space in 2023.
Investor Insights: Rob Barmann – What Do You Look for in New MedTech Ventures? (Part 2)
McDermott + Bull Partner Ken Dropiewski talks with Endeavour Vision Partner Rob Barmann about what his team looks for in prospective partners in new venture opportunities.
Recent
Popular
- No commented posts yet